Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF Valuation
Base-case fair value
$1.81
Intrinsic $2.41 · 25% MOS
Base-case summary
Our base-case DCF for ConvaTec (CTEC.XLON) projects 10 years of free cash flow growth at 6.1% for years 1–5 and 3.1% for years 6–10, anchored to 6.1% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $285M in trailing free cash flow, this produces an intrinsic value of $2.41 per share. A 25% safety margin gives a fair value of $1.81.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$285M
Cash & equivalents
$68M
Total debt
$1.5B
Shares outstanding
2.0B